In the early days of the novel coronavirus COVID-19 pandemic, it was believed using NSAID painkillers like ibuprofen could worsen the disease.
But now, UPI reports a new study from Denmark, published Tuesday in the journal PLOS Medicine, shows that’s just not true.
Among NSAID users with COVID-19, the data showed nearly 25% needed to be hospitalized, 5% required admission to the intensive care unit and 6.3% died.
To compare, for those who did not use these drugs but tested positive for COVID-19, 21% were hospitalized, 5% needed ICU care and 6.1% died.
Considering the available evidence, there is no reason to withdraw well-indicated use of NSAIDs during the pandemic. Study authors, University of Southern Denmark and Aarhus University Hospital, Denmark
